Nonprofit · EIN 95-2916590
DOHENY EYE INSTITUTE
Tax-exempt · PASADENA, CA 91103
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $19,472,650 | $23,405,839 | -$3,933,189 | $248,533,441 | $15,448,827 | $233,084,614 |
| June 30, 2024 | 990 | $25,100,576 | $22,024,513 | $3,076,063 | $241,932,449 | $13,737,651 | $228,194,798 |
| June 30, 2023 | 990 | $25,491,176 | $22,617,018 | $2,874,158 | $227,631,156 | $4,896,913 | $222,734,243 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $6,238,541
- of which government grants
- $2,994,217
- Program service revenue
- $6,121,156
- Investment income
- $5,998,524
- Royalties
- $91
- Net rental income
- $1,114,338
- Net gain from sales of assets
- $3,717,890
- Other revenue
- $1,114,429
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $2,756,240
- Other salaries and wages
- $7,319,129
- Salaries, compensation and benefits (total)
- $14,148,178
- Professional fundraising fees
- $0
- Legal fees
- $330,455
- Accounting fees
- $172,525
- Occupancy
- $54,915
- Travel
- $384,285
- Depreciation
- $2,531,891
- Program services (functional)
- $12,975,041
- Management and general (functional)
- $8,629,084
- Fundraising (functional)
- $1,801,714
Balance sheet and other
- Total assets, start of year
- $241,932,449
- Total assets, end of year
- $248,533,441
- Total liabilities, end of year
- $15,448,827
- Net assets, end of year
- $233,084,614
- Land, buildings and equipment
- $109,311,679
- Publicly traded securities
- $128,103,962
- Net assets without donor restrictions
- $181,876,416
- Net assets with donor restrictions
- $51,208,198
- Gross unrelated business income
- $17,362
- Gross receipts
- $154,052,818
- Employees
- 135
- Volunteers
- 25
- Year formed
- 1947
- State of legal domicile
- CA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MARISSA GOLDBERG | CEO Trustee or director, Officer | 50 | $811,410 | $74,634 |
| Deborah Ann Ferrington | Chief Scientific Officer Highest-paid employee | 37.5 | $433,500 | $51,120 |
| SRINIVAS R SADDA MD | Professor Highest-paid employee | 37.5 | $276,000 | $27,600 |
| MOLLY ANN WOODS | Chief Dev. & Pub. Aff. Officer Highest-paid employee | 37.5 | $231,750 | $33,506 |
| KENT BERKELEY TEPPER | IT DIRECTOR Highest-paid employee | 37.5 | $196,175 | $36,238 |
| STEVEN DANIEL MACGREGOR | DIRECTOR OF FINANCE, TREASURER Officer | 37.5 | $178,244 | $46,468 |
| Daniel Katz | Administrative Director Highest-paid employee | 37.5 | $162,743 | $52,958 |
| Cecilia Zamudio | Assoc. Dir. Comm., Secretary Officer | 37.5 | $105,367 | $38,527 |
| JAMES GIPSON | VICE CHAIRMAN Trustee or director, Officer | 3 | $0 | $0 |
| CHARLES T FOSCUE | CHAIRMAN Trustee or director, Officer | 1.5 | $0 | $0 |
| ROBERT SMITH III | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| JAY S WINTROB | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| RONALD L OLSON | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| STEPHEN A RALPH | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| STEVEN E FELDON | DIRECTOR Trustee or director | 1 | $0 | $0 |
6 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| JOHN R CLEATOR | DIRECTOR Trustee or director | 0.25 | $0 |
| KATHLEEN M DUNCAN | DIRECTOR Trustee or director | 0.25 | $0 |
| GEOFFREY H GEE | DIRECTOR Trustee or director | 0.25 | $0 |
| ERIC L SMALL | DIRECTOR Trustee or director | 0.25 | $0 |
| ROBERT MALONEY | DIRECTOR Trustee or director | 0.25 | $0 |
| MARK SAMUELS | DIRECTOR Trustee or director | 0.25 | $0 |
990 for the year ended June 30, 2024: 21 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MARISSA GOLDBERG | CEO Trustee or director, Officer | 50 | $551,250 | $74,241 |
| Deborah Ann Ferrington | Chief Scientific Officer Highest-paid employee | 37.5 | $425,000 | $16,512 |
| SRINIVAS R SADDA MD | Professor Highest-paid employee | 37.5 | $277,807 | $28,405 |
| MOLLY ANN WOODS | Chief Dev. & Pub. Aff. Officer Highest-paid employee | 37.5 | $225,000 | $27,039 |
| KENT BERKELEY TEPPER | IT DIRECTOR Highest-paid employee | 37.5 | $191,390 | $35,027 |
| STEVEN DANIEL MACGREGOR | DIRECTOR OF FINANCE, TREASURER Officer | 37.5 | $175,610 | $45,112 |
| RAM KANNAN | SCIENTIST Highest-paid employee | 37.5 | $171,518 | $28,826 |
| CECILIA ZAMUDIO | ASSOC. DIR. COMM., SECRETARY Officer | 37.5 | $103,301 | $36,464 |
| JAMES GIPSON | VICE CHAIRMAN Trustee or director, Officer | 3 | $0 | $0 |
| CHARLES T FOSCUE | CHAIRMAN Trustee or director, Officer | 1.5 | $0 | $0 |
| ROBERT L SMITH III | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| JAY S WINTROB | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| RONALD L OLSON | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| STEPHEN A RALPH | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| STEVEN E FELDON | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN R CLEATOR | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| KATHLEEN M DUNCAN | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| GEOFFREY H GEE | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| ERIC L SMALL | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| ROBERT MALONEY | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| MARK SAMUELS | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
990 for the year ended June 30, 2023: 19 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MARISSA GOLDBERG | CEO & SECRETARY Trustee or director, Officer | 50 | $656,250 | $68,485 |
| SRINIVAS R SADDA MD | Professor Highest-paid employee | 37.5 | $326,449 | $31,148 |
| Deborah Ann Ferrington | Chief Scientific Officer Highest-paid employee | 37.5 | $276,250 | $8,539 |
| KENT BERKELEY TEPPER | IT DIRECTOR Highest-paid employee | 37.5 | $185,974 | $30,938 |
| STEVEN DANIEL MACGREGOR | DIRECTOR OF FINANCE Highest-paid employee | 37.5 | $172,232 | $43,463 |
| RAM KANNAN | SCIENTIST Highest-paid employee | 37.5 | $163,721 | $27,463 |
| JAMES GIPSON | VICE CHAIRMAN Trustee or director, Officer | 3 | $0 | $0 |
| CHARLES T FOSCUE | CHAIRMAN Trustee or director, Officer | 1.5 | $0 | $0 |
| ROBERT L SMITH III | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| JAY S WINTROB | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| RONALD L OLSON | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| STEPHEN A RALPH | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| STEVEN E FELDON | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN R CLEATOR | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| KATHLEEN M DUNCAN | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| GEOFFREY H GEE | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| ERIC L SMALL | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| ROBERT MALONEY | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
| MARK SAMUELS | DIRECTOR Trustee or director | 0.25 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 150 N ORANGE GROVE BLVD, PASADENA, CA 91103-3534
- In care of
- % KASHIF KHAN
- Principal officer (990 for 2024)
- MARISSA GOLDBERG, 150 ORANGE GROVE AVE, PASADENA, CA 91103
- Signed the 990
- MARISSA GOLDBERG, CEO
- Phone
- (323) 342-7100
- Website
- WWW.DOHENY.ORG
- Return prepared by
- Maginnis Knechtel & McIntyre LLP
California records
California keeps its own records of charities and corporations. Search them by EIN 95-2916590 or by the name DOHENY EYE INSTITUTE.
- Attorney General, Registry of Charities and Fundraisers
- Registration status and filed reports (CT-TR-1, RRF-1)
- Secretary of State, bizfile Online
- Corporation status, entity number, agent for service
- Franchise Tax Board
- Entity status letter (state tax exemption, good standing)
Mission
TO FURTHER THE CONSERVATION, IMPROVEMENT AND RESTORATION OF HUMAN EYESIGHT" (MRS. DOHENY - 1947).
Program accomplishments
- THE MISSION OF THE DOHENY EYE INSTITUTE (DEI), TO FURTHER THE CONSERVATION, IMPROVEMENT AND RESTORATION OF HUMAN EYESIGHT, IS GUIDED BY THE FOLLOWING OBJECTIVES: 1. TO INCREASE KNOWLEDGE OF THE HUMAN EYE, ITS CONDITIONS AND DISEASES, THROUGH RESEARCH; 2. TO TRANSMIT THIS KNOWLEDGE THROUGH EDUCATION, TRAINING, AND COMMUNITY SERVICE; AND 3. TO FACILITATE THE APPLICATION OF ITS RESEARCH TO IMPROVE PATIENT CARE AND FOSTER FURTHER RESEARCH. RESEARCH ACTIVITIES FOR THE PERIOD AND SELECTED FOR LONG-TERM FOCUS INCLUDE: RETINAL AND MACULAR DEGENERATION RESEARCH THROUGH THE STUDY OF RETINAL PIGMENT EPITHELIUM AND THE USE OF ADVANCED RETINAL IMAGING IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION (AMD) AND IMAGE ANALYSIS USING ARTIFICIAL INTELLEGENCE; OPTIC NERVE RESEARCH AND INVESTIGATIONS OF DISEASES INVOLVING RETINAL GANGLION CELLS; INVESTIGATIONS OF RETINAL VASCULAR STIFFNESS AND ALTERED IMMUNE CELL REGULATION AS POTENTIAL CAUSATIVE FACTORS IN DIABETIC RETINOPATHY; RESEARCH FOCUSED ON DEFINING THE MOLECULAR DETAILS LINKING MITOCHONDRIAL DYSFUNCTION AND ALTERED SIGNALING BETWEEN RETINAL NEURONS. On December 18, 2013, the Doheny Eye Institute executed an agreement with the University of California at Los Angeles (UCLA) for a 99 year affiliation. The purpose of this affiliation is to carry out the Institute's mission -- to further the conservation, improvement, and restoration of human eyesight -- through research, education, and clinical care (clinical care is provided directly by UCLA). Both the Institute and UCLA-Stein Eye Institute are dedicated to providing the public with the highest quality of ophthalmic care and the most innovative and strategic research for the improvement of human eyesight. IN NOV. 2021 DOHENY EYE INSTITUTE (DEI) MOVED TO ITS NEW LOCATION - 150 ORANGE GROVE BLVD IN PASADENA, CA. NEW AREAS OF RESEARCH DEI IS STUDYING THE MECHANISMS RESPONSIBLE FOR DEVELOPMENT OF AGE-RELATED MACULAR DEGENERATION (AMD), THE NUMBER ONE CAUSE OF BLINDNESS AMONG INDIVIDUALS OVER 60 YEARS OLD IN THE USA. THE RISK OF DEVELOPING AMD IS SIGNIFICANTLY INCREASED WHEN SPECIFIC GENES ARE MUTATED. ONE NEW STUDY IS FOCUSED ON STUDYING THE RETINAL CELLS IN THE POPULATION OF PATIENTS HARBORING A SPECIFIC MUTATION IN A GENE INVOLVED IN THE IMMUNE SYSTEM. A SECOND STUDY IS FOCUSED ON A DIFFERENT GENE OF UNKNOWN FUNCTION BUT WITH HIGH IMPACT ON AMD. THE RESEARCHERS ARE STUDYING RETINAL CELLS GENERATED FROM AMD PATIENTS THAT HAVE THESE GENETIC DEFECTS. INFORMATION FROM THESE TWO STUDIES IS CRITICAL FOR DEVELOPMENT OF NEW THERAPIES FOR AMD THAT TARGET WHAT IS CAUSING THE DISEASE. IN OTHER STUDIES, DEI SCIENTISTS HAVE BEEN INVOLVED IN DEVELOPING NEW AND FASTER WAYS TO INTERPRET RETINAL IMAGES IN HUMAN PATIENTS USING ARTIFICIAL INTELLIGENCE (AI). IN TWO DIFFERENT STUDIES, AI-BASED APPROACHES FOR AUTOMATED INTERPRETATION OF IMAGES FROM PATIENTS WITH RETINAL ATROPHY DUE TO EITHER STARGARDT'S DISEASE OR AMD INCORPORATES INFORMATION FROM MULTIPLE IMAGING MODALITIES. ADDITIONALLY, BY FOLLOWING PATIENT IMAGES OVER TIME, AN AI-BASED AUTOMATED ALGORITHM IS BEING DEVELOPED TO PREDICT THE DEVELOPMENT AND PROGRESSION OF ATROPHY OVER TIME. DEI CONTINUES TO DEVELOP CUTTING EDGE IMAGING TECHNOLOGY, INCLUDING A NOVEL ADAPTIVE OPTICS NEAR-CONFOCAL OPHTHALMOSCOPE (AONCO) THAT ENABLES PRECISE EVALUATION OF THE DYNAMIC MOVEMENT OF RED BLOOD CELLS WITHIN RETINAL CAPILLARIES, REFERRED TO AS "HIGHER-ORDER DYNAMICS". BY MONITORING RED BLOOD CELL VELOCITY WITHIN A CARDIAC CYCLE, THEY WILL OBTAIN CRUCIAL INFORMATION ABOUT VASCULAR HEALTH, NOT ONLY OF THE RETINA, BUT ALSO OF THE CENTRAL NERVOUS SYSTEM. THIS INSTRUMENT IS BEING USED TO ESTABLISH CLINICAL BIOMARKERS OF CEREBRAL SMALL VESSEL DISEASE, A PRECURSOR TO DEMENTIA. THIS WORK IS IMPORTANT BECAUSE IT DEMONSTRATES HOW THE RETINA CAN INFORM CLINICIANS ABOUT SYSTEMIC HEALTH, WHICH IS A NEW FIELD OF RESEARCH KNOWN AS "OCULOMICS". DEI HAS ALSO DEVELOPED A PIONEERING ADAPTIVE OPTICS IMAGING INSTRUMENT THAT INTEGRATES SCANNING LASER OPHTHALMOSCOPY AND OPTICAL COHERENCE TOMOGRAPHY (AO-SLO-OCT). THIS INSTRUMENT CAN IMAGE THE RETINA WITH A 3-D SPATIAL RESOLUTION, ALLOWING FOR IN-VIVO ULTRASTRUCTURE ASSESSMENT OF INDIVIDUAL PHOTORECEPTORS IN BOTH EN FACE AND CROSS-SECTIONAL PLANES. THE IMPORTANCE IS THAT THIS ADAPTIVE OPTICS IMAGING OVERCOMES THE LIMITATIONS PRESENTED BY OPTICAL DEFECTS IN LIVING EYES, ALLOWING FOR HIGH RESOLUTION IMAGES OF NOT ONLY PHOTORECEPTORS, BUT ALSO THE RETINAL PIGMENT EPITHELIAL CELLS AND THE CHORIOCAPILLARIS IN THE STUDY OF VARIOUS CHORIORETINAL DISEASES, INCLUDING AMD. ANOTHER IMAGING TECHNIQUE USED BY DEI SCIENTISTS IS THE USE OF CALCIUM IMAGING IN CONJUNCTION WITH CONFOCAL MICROSCOPY TO CHARACTERIZE THE EFFECTS OF OXIDATIVE STRESS ON THE RETINAL GANGLION CELLS. THESE EXPERIMENTS WILL IDENTIFY THE EARLY DEFICITS IN GANGLION CELL ELECTROPHYSIOLOGICAL FUNCTION RESULTING FROM MITOCHONDRIAL DYSFUNCTION. BY CAREFULLY ANALYZING THE EARLIEST SIGNS OF CHANGES TO PHOTORECEPTOR RESPONSE AND SYNAPTIC OUTPUT TO BIPOLAR CELLS, THIS DETECTION AND INTERPRETATION COULD LEAD TO DIAGNOSTIC CLUES THAT AID DETECTION OF PERSONS AT HIGHER RISK OF GLAUCOMA OR OPTIC NEUROPATHY. AN ADDITIONAL NEW AREA INVOLVES STUDIES AIMED AT UNDERSTANDING THE EARLY STAGES OF DIABETIC RETINOPATHY. INVESTIGATIONS ARE CENTERED AROUND HOW INFLAMMATION AND CELLS FROM THE IMMUNE SYSTEM CAN MEDIATED DEGENERATION OF INNER RETINAL VESSELS IN DIABETIC RETINOPATHY. THESE STUDIES, INTEGRATING VASCULAR BIOLOGY, IMMUNOLOGY, AND MECHANOBIOLOGY, HAVE LED TO A UNIQUE HYPOTHESIS THAT ALTERED VASCULAR STIFFNESS COULD BE KEY IN THE DEVELOPMENT OF EARLY DIABETIC RETINOPATHY. THIS FINDING IS IMPORTANT BECAUSE THE WORK, REVEALING A PREVIOUSLY UNRECOGNIZED MECHANISM UNDERLYING THE PATHOGENESIS, COULD LEAD TO EARLY TREATMENTS FOR DIABETIC RETINOPATHY.Expenses $12,975,041 · revenue $6,121,156
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 95-2916590
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1973
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $248,533,441
- Income (IRS master file)
- $154,052,818
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $19,472,650 | $23,405,839 | $248,533,441 | XML |
| 990-T | June 2025 | – | – | – | IRS |
| 990 | June 2024 | $25,100,576 | $22,024,513 | $241,932,449 | IRS |
| 990-T | June 2024 | – | – | – | IRS |
| 990 | June 2023 | $25,491,176 | $22,617,018 | $227,631,156 | XML |
| 990-T | June 2023 | – | – | – | IRS |
| 990 | June 2022 | $66,100,953 | $19,877,758 | $229,360,664 | IRS |
| 990-T | June 2022 | – | – | – | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2019 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 95-2916590).
Questions about DOHENY EYE INSTITUTE
- What is the EIN of DOHENY EYE INSTITUTE?
- The employer identification number (EIN) of DOHENY EYE INSTITUTE is 95-2916590.
- Is DOHENY EYE INSTITUTE tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1973.
- Are donations to DOHENY EYE INSTITUTE tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does DOHENY EYE INSTITUTE file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of DOHENY EYE INSTITUTE due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did DOHENY EYE INSTITUTE last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of DOHENY EYE INSTITUTE?
- The 990 for the year ended June 30, 2025 names MARISSA GOLDBERG.
- Who are the officers and directors of DOHENY EYE INSTITUTE?
- The 990 for the year ended June 30, 2025 lists 21 people; 8 received compensation from the organization, the highest $811,410 (MARISSA GOLDBERG, CEO).
- How much revenue does DOHENY EYE INSTITUTE have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $19,472,650, expenses of $23,405,839 and total assets of $248,533,441 at year end.
Other nonprofits in PASADENA
- CALIFORNIA INSTITUTE OF TECHNOLOGY EIN 95-1643307 · last filed 990 for 2025
- PASADENA HOSPITAL ASSOCIATION LTD EIN 95-1644036 · last filed 990 for 2025
- CALSTART INC EIN 95-4375022 · last filed 990 for 2025
- CREDIT UNIONS IN THE STATE OF CALIFORNIA EIN 95-1288265 · last filed 990 for 2024
- OPERATING ENGINEERS HEALTH & WELFARE FUND EIN 95-6034886 · last filed 990 for 2025
- TEAMSTERS MISCELLANEOUS SECURITY FUND EIN 95-6060502 · last filed 990 for 2025
- CALIFORNIA IRONWORKERS FIELD WELFARE PLAN EIN 95-6042868 · last filed 990 for 2025
- ART CENTER COLLEGE OF DESIGN EIN 95-1921340 · last filed 990 for 2025